Evidence map›Paper›PMID 33317214›Full record

ArticleJournal of clinical medicine2020

Generic and Respiratory-Specific Quality of Life in Non-Hospitalized Patients with COVID-19.

Roy Meys, Jeannet M Delbressine, Yvonne M J Goërtz, Anouk W Vaes, Felipe V C Machado, Maarten Van Herck, Chris Burtin, Rein Posthuma, Bart Spaetgens, Frits M E Franssen and 6 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Roy MeysDepartment of Research and Development, Ciro, 6085 NM Horn, The Netherlands.ORCID 0000-0002-4855-530X
Jeannet M DelbressineDepartment of Research and Development, Ciro, 6085 NM Horn, The Netherlands.ORCID 0000-0002-5203-1592
Yvonne M J GoërtzDepartment of Research and Development, Ciro, 6085 NM Horn, The Netherlands.ORCID 0000-0003-3453-7220
Anouk W VaesDepartment of Research and Development, Ciro, 6085 NM Horn, The Netherlands.ORCID 0000-0002-4136-1553
Felipe V C MachadoDepartment of Research and Development, Ciro, 6085 NM Horn, The Netherlands.
Maarten Van HerckDepartment of Research and Development, Ciro, 6085 NM Horn, The Netherlands.ORCID 0000-0002-3333-6964
Chris BurtinREVAL-Rehabilitation Research Center, BIOMED-Biomedical Research Institute, Faculty of Rehabilitation Sciences, Hasselt University, 3500 Diepenbeek, Belgium.
Rein PosthumaDepartment of Research and Development, Ciro, 6085 NM Horn, The Netherlands.
Bart SpaetgensDepartment of Internal Medicine, Maastricht University Medical Centre (MUMC+), 6202 AZ Maastricht, The Netherlands.ORCID 0000-0003-3062-2612
Frits M E FranssenDepartment of Research and Development, Ciro, 6085 NM Horn, The Netherlands.ORCID 0000-0002-1633-6356
Yvonne SpiesLung Foundation Netherlands, 3818 LE Amersfoort, The Netherlands.
Herman VijlbriefLung Foundation Netherlands, 3818 LE Amersfoort, The Netherlands.
Alex J Van't HulDepartment of Pulmonary Diseases, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-5514-2327
Daisy J A JanssenDepartment of Research and Development, Ciro, 6085 NM Horn, The Netherlands.ORCID 0000-0002-1827-9869
Martijn A SpruitDepartment of Research and Development, Ciro, 6085 NM Horn, The Netherlands.ORCID 0000-0003-3822-7430
Sarah Houben-WilkeDepartment of Research and Development, Ciro, 6085 NM Horn, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of coronavirus disease 2019 (COVID-19) on quality of life appears to be highly underestimated, especially in patients who have not been admitted to the hospital. Therefore, our aim was to assess respiratory-specific quality of life in addition to generic quality of life in former patients with confirmed/suspected COVID-19 who have never been admitted to the hospital. Members of an online Belgian social support group for patients with confirmed/suspected COVID-19 with persistent complaints, completed an online survey. The five-level EQ-5D (EQ-5D-5L) and the Clinical COPD Questionnaire (CCQ) were used to assess generic and respiratory-specific quality of life, respectively. Data of 210 non-hospitalized patients (88% women, 45 ± 11 years, 79 ± 17 days after symptom onset) were included in the analyses. Mean EQ-5D index and visual analogue scale (EQ-VAS) score was 0.62 ± 0.19 and 50.71 ± 18.87, respectively, with 40% of the patients demonstrating an EQ-5D index that was below the fifth percentile of normative values, indicating poor generic quality of life. The mean CCQ score was 2.01 ± 0.98 points, while 123 respondents (59%) had a total score ≥1.9 points, indicating poor respiratory-specific quality of life. The correlation between EQ-5D index score/EQ-VAS score and CCQ total score was moderate (r = -0.524 and r = -0.374; both

Indexed as

COVID-19quality of lifeSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Identifiers

PMID33317214
PMCPMC7764406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.